Adiponectin receptor agonist AdipoRon improves skeletal muscle function in aged mice
The loss of skeletal muscle function with age, known as sarcopenia, significantly reduces independence and quality of life and can have significant metabolic consequences. Although exercise is effective in treating sarcopenia it is not always a viable option clinically, and currently, there are no p...
Main Authors: | Priya Balasubramanian, Anne E Schaar, Grace E Gustafson, Alex B Smith, Porsha R Howell, Angela Greenman, Scott Baum, Ricki J Colman, Dudley W Lamming, Gary M Diffee, Rozalyn M Anderson |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2022-03-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/71282 |
Similar Items
-
AdipoRon may be benefit for atherosclerosis prevention
by: Maryam Esfahani, et al.
Published: (2017-02-01) -
Potential Role of Adiponectin Receptor Agonist, AdipoRon in Cardiometabolic Disease
by: Eunhee Cho, et al.
Published: (2019-05-01) -
AdipoRon and Other Adiponectin Receptor Agonists as Potential Candidates in Cancer Treatments
by: Ersilia Nigro, et al.
Published: (2021-05-01) -
Anti-Inflammatory Effects of Adiponectin Receptor Agonist AdipoRon against Intervertebral Disc Degeneration
by: Hiroki Ohnishi, et al.
Published: (2023-05-01) -
The Antiviral Potential of AdipoRon, an Adiponectin Receptor Agonist, Reveals the Ability of Zika Virus to Deregulate Adiponectin Receptor Expression
by: Daed El Safadi, et al.
Published: (2023-12-01)